FluoroPharma Medical Price to Free Cash Flow Ratio 2010-2016 | FPMI

FluoroPharma Medical price to free cash flow ratio from 2010 to 2016. Price to free cash flow ratio can be defined as

FluoroPharma Medical Price to Free Cash Flow Ratio 2010-2016 | FPMI

FluoroPharma Medical price to free cash flow ratio from 2010 to 2016. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$195.6B
Stryker (SYK)$137.3B
Boston Scientific (BSX)$122.7B
Medtronic (MDT)$114.6B
EssilorLuxottica (ESLOY)$108.8B
Haleon (HLN)$48.7B
Lonza Group Ag (LZAGY)$46B
ResMed (RMD)$35.1B
Koninklijke Philips (PHG)$30.8B
Terumo (TRUMY)$28.5B
Zimmer Biomet Holdings (ZBH)$22B
Baxter (BAX)$19.9B
Insulet (PODD)$16.3B
Smith & Nephew SNATS (SNN)$13.6B
Bio-Rad Laboratories (BIO)$9.2B
Demant (WILYY)$8.7B
BellRing Brands (BRBR)$7.9B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.3B
Haemonetics (HAE)$4.1B
TG Therapeutics (TGTX)$3.7B
Neogen (NEOG)$3.6B
Prestige Consumer Healthcare (PBH)$3.5B
GN Store Nord (GNNDY)$3.5B
Perrigo (PRGO)$3.5B
Envista Holdings (NVST)$3.4B
QuidelOrtho (QDEL)$3.1B
Agios Pharmaceuticals (AGIO)$2.6B
Green Thumb Industries (GTBIF)$2.2B
Maravai LifeSciences Holdings (MRVI)$2.1B